Natixis Investment Managers International Abbott Laboratories Transaction History

Natixis Investment Managers International

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $84,718 - $102,397	830 Added 19.72%	5,038 $547,000
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $479,796 - $585,080	4,208 New	4,208 $498,000
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $2.2 Million - $2.5 Million	-33,624 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $320,225 - $386,313	5,266 Added 18.57%	33,624 $2.47 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $358,315 - $395,472	6,224 Added 28.12%	28,358 $1.73 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $1.25 Million - $1.41 Million	22,134 New	22,134 $1.33 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $937,199 - $1 Million	-17,459 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $298,837 - $333,533	-6,218 Reduced 26.26%	17,459 $932,000
Q2 2017 Aug 14, 2017	BUY	N/A	23,677	23,677 $1.15 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

Stay updated on Natixis Investment Managers International with notifications on news.